BioWorld - Tuesday, February 3, 2026

BioWorld Science

Dec. 9, 2021

View Archived Issues

Proteogenomics approach identifies neoantigens for T-cell immunotherapy in pediatric brain tumors

Read More

Attenuated T. gondii injection synergizes with PD-L1 checkpoint blockade against mouse tumors

Read More

New model for studying early embryonic development

Read More

Shanghai Meiyue Biotech Development describes new coagulation factor XIa inhibitors

Read More

New CDK9/cyclin T1 inhibitors identified at Algen Biotechnologies

Read More

New ENPP1 inhibitors discovered at Vir Biotechnology

Read More

Edgewise Therapeutics patents myosin inhibitors

Read More

New Wnt signaling activators identified at Biosplice Therapeutics

Read More

EZH2 methylation of p38 linked to breast cancer progression

Read More

Dual BRD4 and ULK3 inhibition as novel therapeutic strategy for TNBC

Read More

Codiak Biosciences tests exosome-based vaccine platform for SARS-CoV-2

Read More

CP-COV03 with dexamethasone produces synergistic effect for severe COVID-19 in hamsters

Read More

Discovery of novel o-aminobenzamide derivative with promising activity in models of gastric cancer

Read More

Smart Immune collaborates with MSK to expand ProTcell pipeline

Read More

New bifunctional piperidinamide derivative as sigma-1 and mu-opioid receptor agonist

Read More

Loss of SETDB1-TRIM28 complex boosts the antitumor effects of immune checkpoint blockade

Read More